Tibor Keler's Insider Trades & SAST Disclosures
Tibor Keler's most recent trade in Celldex Therapeutics Inc. was a trade of 93,000 Incentive Stock Option (right to buy) done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Tibor Keler.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Celldex Therapeutics Inc. | Tibor Keler | EXECUTIVE VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 93,000 | 93,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | EXECUTIVE VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 92,000 | 92,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | EXECUTIVE VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 91,000 | 91,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | Executive VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 91,000 | 91,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | Executive VP & CSO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 108,000 | 108,000 | - | - | Incentive Stock Option (right to buy) | |
| Celldex Therapeutics Inc. | Tibor Keler | Executive VP & CSO | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 09 Jun 2020 | 5,000 | 7,357 (0%) | 0% | 3.0 | 14,954 | Common Stock, par value $0.001 per share |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges